Fatty Liver Disease (MASLD)
A common, often silent condition where fat builds up in the liver — usually linked to diabetes, obesity, or high cholesterol. With diet, exercise, and (in some cases) new medications, the liver can recover.
This article is educational and does not replace your doctor's advice. Seek urgent care for any red-flag symptoms.
What is it?
MASLD stands for Metabolic dysfunction-Associated Steatotic Liver Disease — the modern name for what used to be called "fatty liver disease" or NAFLD. In simple terms, too much fat is stored inside your liver cells. A small amount of fat in the liver is normal; in MASLD the fat builds up to a level that can quietly damage the liver over time.
The disease has stages. The earliest stage is just fat (steatosis). In some people, fat causes inflammation and liver-cell injury — this is called MASH (formerly NASH). Over many years, MASH can lead to scarring (fibrosis), and in a smaller fraction of people, advanced scarring (cirrhosis) and even liver cancer. The good news: at the early stages, MASLD is reversible.
How common is it?
MASLD affects approximately 25–30% of adults worldwide, and the numbers are even higher in the Gulf region. In Saudi Arabia, recent studies estimate that around one in three adults has fatty liver, and the rate climbs to over 50% in adults with type 2 diabetes or obesity. Children and adolescents are increasingly affected too.
Why does it happen?
MASLD is part of a wider problem in how the body handles sugar and fat (called metabolic syndrome). The strongest risk factors are: being overweight (especially carrying extra fat around the waist), type 2 diabetes or pre-diabetes, high blood pressure, high cholesterol or triglycerides, and a diet high in sugar, refined carbs, and processed foods.
MASLD is NOT caused by alcohol. If alcohol is the main driver, doctors call it ALD (alcohol-associated liver disease) instead.
Symptoms
Symptoms — but most people have none
- No symptoms at all (most people)
- Mild tiredness or fatigue
- A dull ache in the upper-right side of the abdomen
- Discovered by chance on a blood test (raised ALT/AST) or an ultrasound
Red flags — seek urgent medical care
Yellowing of the skin or eyes (jaundice)
Possible advanced liver disease — see your doctor within days.
Swelling in the legs or belly
May indicate fluid buildup from cirrhosis. Get an urgent assessment.
Vomiting blood or passing black, tarry stools
A medical emergency — go to the emergency department immediately.
Confusion, unusual sleepiness, or memory problems
Could be liver failure (hepatic encephalopathy). Seek urgent care.
How is it diagnosed?
Diagnosis happens in steps:
Blood tests. Liver enzymes (ALT, AST), full liver function, lipids, blood sugar, and HbA1c. The FIB-4 score (calculated from age, ALT, AST, and platelets) is the modern first-step tool to estimate scarring.
Ultrasound. A simple scan that shows fat in the liver. It cannot tell how scarred the liver is.
FibroScan (transient elastography). A painless 10-minute scan that measures liver stiffness — a marker of scarring. This is becoming the standard staging tool.
MRI elastography or liver biopsy are reserved for cases where staging is uncertain.
What the latest science says
In 2023 the disease was renamed from NAFLD to MASLD by international expert consensus. In 2024, the first medication specifically approved for advanced MASH became available — resmetirom (Rezdiffra). Several other drugs (including GLP-1 agonists like semaglutide) have shown striking improvements in MASLD.
The most important insight remains: weight loss of 7–10% reverses inflammation in most people, and 10–15% can reverse early scarring.
Outlook — what to expect
For most people with early MASLD, the outlook is excellent. With sustained lifestyle changes the liver fully recovers. About 25–30% progress to MASH, and 10–15% of those develop significant scarring over many years. Less than 5% of all MASLD patients eventually develop cirrhosis. What tips the balance is whether the underlying metabolic problems are controlled.
Treatment
Habits & Lifestyle
Daily habits are the single most powerful treatment. The goal is steady weight loss with a more active routine.
- Aim for 5–7% weight loss to improve liver fat; 10% or more to reverse scarring.
- Walk briskly for 30 minutes most days. Two 15-minute walks count too.
- Add 2 sessions of resistance training per week.
- Sleep 7–8 hours.
- Avoid alcohol entirely.
- Get vaccinated against hepatitis A and B.
Diet
No special "liver diet" exists — but the Mediterranean pattern has the strongest evidence.
- Make half your plate vegetables and fruit at every meal.
- Choose whole grains over white bread and white rice.
- Eat fish 2–3 times per week.
- Use olive oil; limit butter, ghee, palm oil.
- Eliminate sugary drinks completely.
- Limit ultra-processed foods to once or twice a week.
- Coffee 3–4 cups daily (unsweetened) protects the liver.
Medications
No medication replaces lifestyle, but several drugs play important supporting roles.
- GLP-1 agonists (semaglutide, tirzepatide) — major option if you also have diabetes or significant obesity.
- Resmetirom (Rezdiffra) — first drug approved for moderate-to-advanced MASH (2024).
- Vitamin E — for some non-diabetic patients with biopsy-proven MASH.
- Tight control of diabetes, cholesterol (statins are SAFE in MASLD), and blood pressure all reduce liver damage.
Procedures & Surgery
For severe obesity (BMI ≥35) with MASLD, bariatric surgery is one of the most effective treatments — it can reverse fibrosis in many patients.
- Sleeve gastrectomy and Roux-en-Y gastric bypass — most common in Saudi Arabia.
- Endoscopic sleeve gastroplasty — no-cut procedure, less weight loss but lower risk.
- Liver transplantation — only for advanced cirrhosis or liver cancer.
Living with the condition
- Track weight weekly, not daily — trends matter more than fluctuation.
- Use a free food-tracking app for 2 weeks at a time.
- Make exercise social — walk with family after dinner.
- Schedule a follow-up FibroScan or blood test every 12 months.
In the Saudi context
In Saudi Arabia, MASLD is now the leading cause of chronic liver disease, ahead of viral hepatitis. The MOH offers fatty liver screening as part of the Sehhaty platform for adults with diabetes or obesity. FibroScan is widely available at major hospitals; many also offer dietitian consultations covered by Class A and B insurance plans. Several Saudi centers run specialized obesity-and-liver clinics combining hepatology, endocrinology, dietetics, and bariatric surgery in one visit.
Questions to ask your doctor
Save this list or print it before your appointment — doctors appreciate prepared patients.
- Based on my blood tests and FIB-4 score, what stage is my MASLD?
- Do I need a FibroScan? How often?
- What weight-loss target should I aim for in the next 6 months?
- Am I a candidate for GLP-1 medications or resmetirom?
- Should I see a dietitian and what insurance coverage applies?
- Are any of my current medications harmful to my liver?
Trusted resources
Medically reviewed by: SGA Hepatology Panel · Last reviewed 24/04/2026